Trials / Completed
CompletedNCT01472900
2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne
A Randomized Split-Face Controlled Trial Comparing Efficacy of 2940 Nanometer Er:YAG Laser to 2.5% BP Gel for the Treatment of Inflammatory Acne
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Acne is one of the most common conditions that patients seek for help in dermatological clinic. Nowadays, conventional treatment including topical agents(retinoids, antibiotics ,antiseptics and keratolytic agents) and systemic agents( antibiotics and retinoids) give a satisfying result but not to every patient. Some patients are not well respond to conventional therapy while some patients are unable to tolerate side effects of the treatments. Therefore, interventions to reduce acne are vigorously experimented . Lights and lasers including intense pulsed light, pulsed dye laser with or without photosensitizer and infrared lasers have been found to be useful in treating active inflammatory acne. Although,pain ,downtime and poor response of comedonal acne are limitations of those lights and lasers therapy. 2940 nm Erbium:YAG laser which has both resurfacing and photothermal effects is our laser of interest to seek for its efficacy in the treatment of inflammatory acne.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 2940 nm Er:YAG laser (DualisXS M002-2A, Fotona®, Fotona d.d, Ljubljana, Slovenia) | 2 passes of 2940nm Er:YAG laser |
| DRUG | Benzoyl Peroxide gel | 2.5% benzoyl peroxide gel apply twice daily on inflammatory acne on the control side of face |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2011-11-17
- Last updated
- 2012-06-19
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01472900. Inclusion in this directory is not an endorsement.